Effectiveness of Dexmedetomidine used as an adjuvant with ropivacaine for ultrasound guided supraclavicular brachial plexus block for Upper limb surgery

Comparative Evaluation of Dexmeditomidine as an Adjuvant to 0.5% Ropivacaine in Supraclavicular Brachial Plexus Block for Upper Limb Surgeries : A Randomized Double Blind Controlled Interventional Study - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/08/092163

Enrollment

Registered

2025-08-01

Start date

Unknown

Completion date

Unknown

Last updated

2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: A Comparative Evaluation of 0.5 % Ropivacaine With Or Without Dexmedetomidine in Supraclavicular Brachial Plexus Block for Upper Limb Surgerie: Group A: Patient will receive USG guided

Eligibility

Inclusion criteria

Inclusion criteria: 1.American Society of Anaesthesiologists physical status I-II 2.Upper limb surgeries below mid humerus level of duration 1-2 hours 3.Body Weight -40-70kgs 4.Subject Willing to Give Written and Informed Consent

Exclusion criteria

Exclusion criteria: 1.Uncooperative Patients. 2. Infection at the site of injection. 3. History of allergy to the study drugs. 4. Bleeding disorder and coagulopathies. 5. History of convulsions, severe neurological deficits

Design outcomes

Primary

Measure	Time frame
To compare the duration of analgesia in the both groups.Timepoint: Duration of Analgesia is the time postoperatively when patient will demand for rescue analgesia or when patient NRS score is equal to or more then 4 in first 24 hours.	—

Secondary

Measure	Time frame
To Study Onset sensory block in both groups. Timepoint: Immediately after block in minutes;To study onset of motor block in both groups.Timepoint: Immediately after block in minutes;To compare Duration of sensory in both groups.Timepoint: Assessed postoperatively in first 24 hours;To compare Duration of Motor block in both groups.Timepoint: Assessed Postoperatively in first 24 hours;To study Hemodynamic Response in both groups.Timepoint: Assessed in first 24 hours after block.;To study side effects and complications if any in both groupsTimepoint: Assessed in first 24 hours after block.	—

Measure

Time frame

To Study Onset sensory block in both groups. Timepoint: Immediately after block in minutes;To study onset of motor block in both groups.Timepoint: Immediately after block in minutes;To compare Duration of sensory in both groups.Timepoint: Assessed postoperatively in first 24 hours;To compare Duration of Motor block in both groups.Timepoint: Assessed Postoperatively in first 24 hours;To study Hemodynamic Response in both groups.Timepoint: Assessed in first 24 hours after block.;To study side effects and complications if any in both groupsTimepoint: Assessed in first 24 hours after block.

—

Countries

India

Contacts

Public ContactKaran Swami

RNT Medical College Udaipur

karanswami0099@gmail.com9991909947

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026